Search for: "In Re: Pfizer Securities Litigation" Results 1 - 20 of 56
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jun 2012, 11:44 am by Schachtman
Lee-Jen Wei at 8, 9 (May 5, 2010), in Securities Litig. [read post]
19 Nov 2012, 12:29 am by Kevin LaCroix
  The opt-out litigation raises much bigger problems for Pfizer and the other defendants. [read post]
1 Mar 2009, 9:00 pm
In a nutshell, plaintiffs pleaded that Pfizer, "working in partnership with the Nigerian government, failed to secure the informed consent" of children (or their guardians) who were enrolled in an allegedly dangerous clinical trial of the drug Trovan. [read post]
19 Sep 2013, 9:53 am by Bexis
Pfizer, Inc., 712 F.3d 60 (1st Cir. 2013) – all of which also travel under the heading, In re Neurontin Marketing and Sales Practices Litigation. [read post]
20 Nov 2012, 12:38 am by Kruttika Vijay
Usually the defendants in litigation with freelance authors about re-publication rights, publishing authors are lobbying to have Google pay for the reproduction of news articles in the face of steeply declining sales. [read post]
2 Sep 2009, 11:22 pm
July 25, 2008) (Texas statute); In re Aredia & Zometa Products Liability Litigation, 2008 WL 913087, at *2 (M.D. [read post]
15 Apr 2015, 12:09 pm
”  Id. at *37.Finally, with regard to “duplication or proliferation of litigation – the seventh statutory factor” the Panel disagreed with petitioners’ contention that they would be forced to start at “ground zero” if required to re-file in their home states, pointing out that “any plaintiff family who re-files in their home state will have access to the significant discovery that Pfizer has already… [read post]
25 Jun 2009, 4:29 am
Feb. 19, 2009); In re Nuvelo, Inc., Securities Litigation, 2008 WL 5114325, at *2 (N.D. [read post]
7 Jan 2013, 12:38 am by Kevin LaCroix
  And in the world of accounting, Francine McKenna has listed top 20 posts from her own re: The Auditors blog (here). [read post]